 |
PDBsum entry 2q2y
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
|
PDB id:
|
|
|
|
| Name: |
|
Cell cycle
|
|
|
Title:
|
|
Crystal structure of ksp in complex with inhibitor 1
|
|
Structure:
|
|
Kinesin-like protein kif11. Chain: a, b. Synonym: kinesin-related motor protein eg5, kinesin-like spindle protein hksp, thyroid receptor-interacting protein 5, trip-5, kinesin-like protein 1. Engineered: yes
|
|
Source:
|
|
Homo sapiens. Human. Organism_taxid: 9606. Gene: kif11, eg5, knsl1, trip5. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
|
|
2.50Å
|
R-factor:
|
0.193
|
R-free:
|
0.252
|
|
|
Authors:
|
|
Y.Yan
|
|
Key ref:
|
|
A.J.Roecker
et al.
(2007).
Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP.
Bioorg Med Chem Lett,
17,
5677-5682.
PubMed id:
DOI:
|
|
|
Date:
|
|
|
29-May-07
|
Release date:
|
18-Sep-07
|
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
|
Headers
|
|
|
|
References
|
|
|
|
|
|
|
|
P52732
(KIF11_HUMAN) -
Kinesin-like protein KIF11 from Homo sapiens
|
|
|
|
Seq:
Struc:
|
|
|
|
1056 a.a.
330 a.a.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Key: |
 |
PfamA domain |
|
|
 |
Secondary structure |
|
 |
CATH domain |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
17:5677-5682
(2007)
|
|
PubMed id:
|
|
|
|
|
|
| |
|
Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP.
|
|
A.J.Roecker,
P.J.Coleman,
S.P.Mercer,
J.D.Schreier,
C.A.Buser,
E.S.Walsh,
K.Hamilton,
R.B.Lobell,
W.Tao,
R.E.Diehl,
V.J.South,
J.P.Davide,
N.E.Kohl,
Y.Yan,
L.C.Kuo,
C.Li,
C.Fernandez-Metzler,
E.A.Mahan,
T.Prueksaritanont,
G.D.Hartman.
|
|
|
|
|
| |
ABSTRACT
|
|
|
|
| |
|
|
Inspired by previous efforts in the pyrazolobenzoxazine class of KSP inhibitors,
the design and synthesis of 1,4-diaryl-4,5-dihydropyrazole inhibitors of KSP are
described. Crystallographic evidence of binding mode and in vivo potency data is
also highlighted.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
|
| |
PubMed id
|
|
Reference
|
|
|
|
|
|
C.Jiang,
Q.You,
F.Liu,
W.Wu,
Q.Guo,
J.Chern,
L.Yang,
and
M.Chen
(2009).
Design, synthesis and evaluation of tetrahydroisoquinolines as new kinesin spindle protein inhibitors.
|
| |
Chem Pharm Bull (Tokyo),
57,
567-571.
|
|
|
|
|
|
|
D.Huszar,
M.E.Theoclitou,
J.Skolnik,
and
R.Herbst
(2009).
Kinesin motor proteins as targets for cancer therapy.
|
| |
Cancer Metastasis Rev,
28,
197-208.
|
|
|
|
|
|
|
J.A.Lewis,
E.P.Lebois,
and
C.W.Lindsley
(2008).
Allosteric modulation of kinases and GPCRs: design principles and structural diversity.
|
| |
Curr Opin Chem Biol,
12,
269-280.
|
|
|
|
|
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|
Links
